NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Efrat Dotan, Louise C. Walter, Ilene Browner, Katherine Clifton, Harvey Jay Cohen, Martine Extermann, Cary P. Gross, Sumati Gupta, Genevieve Hollis, Joleen M. Hubbard, Reshma Jagsi, Nancy L. Keating, Elizabeth R. Kessler, Thuy T. Koll, Beatriz Korc‐Grodzicki, June M. McKoy, Sumi Misra, Dominic H. Moon, Tracey L. O’Connor, Cynthia Owusu, Ashley Rosko, Marcia M. Russell, Mina S. Sedrak, Fareeha Siddiqui, Amy Stella, Derek L. Stirewalt, Ishwaria M. Subbiah, William P. Tew, Grant R. Williams, Liz Hollinger, Giby V. George, Hema Sundar
Abstract
The NCCN Guidelines for Older Adult Oncology address specific issues related to the management of cancer in older adults, including screening and comprehensive geriatric assessment (CGA), assessing the risks and benefits of treatment, preventing or decreasing complications from therapy, and managing patients deemed to be at high risk for treatment-related toxicity. CGA is a multidisciplinary, in-depth evaluation that assesses the objective health of the older adult while evaluating multiple domains, which may affect cancer prognosis and treatment choices. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines providing specific practical framework for the use of CGA when evaluating older adults with cancer.